Health Care
Blog
Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome
Pharmacy benefit managers (PBMs) deploy numerous anticompetitive actions, which have not gone unnoticed. The Federal Trade Commission (FTC) has launched an inquiry to examine whether PBMs have adverse impacts “on the access and affordability of prescription drugs.” The government’s probe is welcome news. But there are many detrimental PBM practices that are ...
Commentary
Inflation Reduction Act Bad Enough, Side Effects Worse
Among the recently passed Inflation Reduction Act’s most destructive provisions are the price controls it puts on prescription drugs through Medicare. These price controls are certain to have a chilling effect on pharmaceutical innovation in the years ahead. But the precise manner in which the IRA will undermine biomedical research and development ...
Commentary
The Ultimate Price Of Government Price Controls
Democrats have nudged the U.S. healthcare system closer to Canadian-style socialism with their recently signed, and dubiously named, Inflation Reduction Act. The IRA will impose a collection of price caps on prescription drugs. Canada has long forcibly controlled drug prices—and thereby deprived patients of access to cutting-edge care. The story ...
Commentary
D.C. wants to make cancer patients wait for treatment
The powers that be in Washington are renewing their campaign to gain greater control over Americans’ ability to access life-saving drugs. Lawmakers and regulators alike have decided to wage war on one of the few components of our health care system that works well — the Food and Drug Administration’s ...
Commentary
What we need from our post-Fauci public health officials
Dr. Anthony Fauci announced this week that he will step down from his posts as director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden at the end of the year. Just days earlier, Dr. Rochelle Walensky, director of the Centers for Disease Control ...
Commentary
In the physician shortage, there’s a solution patients agree with — but the laws don’t
The quickest way to get less of something is to regulate it. Nowhere is that more apparent than in the health sector, which suffers from a chronic shortage of physicians, particularly in primary care. And it’s about to get worse. According to the Association of American Medical Colleges, the United States ...
Featured
NEW BRIEF: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More
SACRAMENTO – Biosimilars competition saves patients and the health care system over $11 billion annually and could generate even more savings if the broken drug pricing system were reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Commentary
Inflation Reduction Act Nightmare Targets Life-Saving Meds
President Joe Biden returned from vacation in South Carolina this week to sign the Inflation Reduction Act into law. The country would have been better off had he stayed at the beach. The IRA includes a combination of massive tax increases, innovation-destroying price controls, and debt-funded spending commitments. That might be music to the ears ...
Business & Economics
What Will Inflation Reduction Act Mean for Health Care, Climate, and the Economy?
Now that it has been passed by Congress, PRI’s top experts join us to discuss what the so-called Inflation Reduction Act will mean for you and your family.
Commentary
VA issues illustrate pitfalls of government health care
In the fall of 2020, a patient in Augusta, Georgia, went to the local Veterans Affairs medical center for a minimally invasive urologic surgery, according to a new report from the VA’s Office of Inspector General. Less than two weeks later, the OIG reports, he was dead. The Inspector General ...
Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome
Pharmacy benefit managers (PBMs) deploy numerous anticompetitive actions, which have not gone unnoticed. The Federal Trade Commission (FTC) has launched an inquiry to examine whether PBMs have adverse impacts “on the access and affordability of prescription drugs.” The government’s probe is welcome news. But there are many detrimental PBM practices that are ...
Inflation Reduction Act Bad Enough, Side Effects Worse
Among the recently passed Inflation Reduction Act’s most destructive provisions are the price controls it puts on prescription drugs through Medicare. These price controls are certain to have a chilling effect on pharmaceutical innovation in the years ahead. But the precise manner in which the IRA will undermine biomedical research and development ...
The Ultimate Price Of Government Price Controls
Democrats have nudged the U.S. healthcare system closer to Canadian-style socialism with their recently signed, and dubiously named, Inflation Reduction Act. The IRA will impose a collection of price caps on prescription drugs. Canada has long forcibly controlled drug prices—and thereby deprived patients of access to cutting-edge care. The story ...
D.C. wants to make cancer patients wait for treatment
The powers that be in Washington are renewing their campaign to gain greater control over Americans’ ability to access life-saving drugs. Lawmakers and regulators alike have decided to wage war on one of the few components of our health care system that works well — the Food and Drug Administration’s ...
What we need from our post-Fauci public health officials
Dr. Anthony Fauci announced this week that he will step down from his posts as director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden at the end of the year. Just days earlier, Dr. Rochelle Walensky, director of the Centers for Disease Control ...
In the physician shortage, there’s a solution patients agree with — but the laws don’t
The quickest way to get less of something is to regulate it. Nowhere is that more apparent than in the health sector, which suffers from a chronic shortage of physicians, particularly in primary care. And it’s about to get worse. According to the Association of American Medical Colleges, the United States ...
NEW BRIEF: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More
SACRAMENTO – Biosimilars competition saves patients and the health care system over $11 billion annually and could generate even more savings if the broken drug pricing system were reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Inflation Reduction Act Nightmare Targets Life-Saving Meds
President Joe Biden returned from vacation in South Carolina this week to sign the Inflation Reduction Act into law. The country would have been better off had he stayed at the beach. The IRA includes a combination of massive tax increases, innovation-destroying price controls, and debt-funded spending commitments. That might be music to the ears ...
What Will Inflation Reduction Act Mean for Health Care, Climate, and the Economy?
Now that it has been passed by Congress, PRI’s top experts join us to discuss what the so-called Inflation Reduction Act will mean for you and your family.
VA issues illustrate pitfalls of government health care
In the fall of 2020, a patient in Augusta, Georgia, went to the local Veterans Affairs medical center for a minimally invasive urologic surgery, according to a new report from the VA’s Office of Inspector General. Less than two weeks later, the OIG reports, he was dead. The Inspector General ...
